Odyssey Therapeutics Statistics
NASDAQ: ODTXHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
16.96-1.38 (-7.52%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Odyssey Therapeutics by the numbers
Odyssey Therapeutics has a market capitalization of $815.2 million based on 48.07M shares outstanding. With trailing EPS of $-6.33, Odyssey Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 14.9% below its 50-day average and 13.8% below its 200-day average.
Average daily trading volume is 329.31K shares, or about $5.6 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
ODTX valuation vs. peer median
| Metric | ODTX | Peer median | Difference |
|---|---|---|---|
| Market cap | $815.23M | $759.09M | +7% |
| Avg. volume | 329.31K | 904.98K | -64% |
Peer median across 8 companies: BBTX, PRME, MGTX, IMTX, GLUE, AURA, SLDB, ATTO.
Valuation
- Market cap
- $815.23M
- EPS (TTM)
- $-6.33
- Shares outstanding
- 48.07M
Price and trading
- Previous close
- 18.34
- Open
- 17.65
- Day range
- 16.46 – 18.08
- 52-week range
- 15.10 – 29.05
- Beta
- —
- Volume
- 677.84K
- Average volume
- 329.31K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 4, 2026
Additional statistics
- Market Cap
- 815.23M
- Forward Pe
- -3.82
- Eps
- -6.33
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 29.05
- Week52 Low
- 15.10
- Avg Volume
- 329.31K
- Shares Outstanding
- 48.07M
- Ma50
- 19.93
- Ma200
- 19.68
- Earnings Date
- Nov 4, 2026
- Pct From52w High
- -41.62%
- Pct From52w Low
- 12.32%